0001209191-17-042901.txt : 20170703
0001209191-17-042901.hdr.sgml : 20170703
20170703192040
ACCESSION NUMBER: 0001209191-17-042901
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170515
FILED AS OF DATE: 20170703
DATE AS OF CHANGE: 20170703
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AMARIN CORP PLC\UK
CENTRAL INDEX KEY: 0000897448
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: X0
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: FIRST FLOOR, BLOCK 3, THE OVAL,
STREET 2: SHELBOURNE ROAD, BALLSBRIDGE
CITY: DUBLIN
STATE: L2
ZIP: 00000
BUSINESS PHONE: 353 1 6699 020
MAIL ADDRESS:
STREET 1: FIRST FLOOR, BLOCK 3, THE OVAL,
STREET 2: SHELBOURNE ROAD, BALLSBRIDGE
CITY: DUBLIN
STATE: L2
ZIP: 00000
FORMER COMPANY:
FORMER CONFORMED NAME: AMARIN PHARMACEUTICALS PLC
DATE OF NAME CHANGE: 20000201
FORMER COMPANY:
FORMER CONFORMED NAME: ETHICAL HOLDINGS PLC
DATE OF NAME CHANGE: 19930322
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kennedy Joseph T
CENTRAL INDEX KEY: 0001408920
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-21392
FILM NUMBER: 17945988
MAIL ADDRESS:
STREET 1: C/O TRANSCEPT PHARMACEUTICALS, INC.
STREET 2: 1003 W. CUTTING BLVD., SUITE 110
CITY: POINT RICHMOND
STATE: CA
ZIP: 94804
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2017-05-15
0
0000897448
AMARIN CORP PLC\UK
AMRN
0001408920
Kennedy Joseph T
C/O AMARIN PHARMA, INC.
1430 ROUTE 206
BEDMINSTER
NJ
07921
0
1
0
0
General Counsel
Ordinary Shares
2017-06-29
4
S
0
151768
3.9786
D
130591
D
Ordinary Shares
2017-06-30
4
M
0
47187
A
177778
D
Ordinary Shares
2017-06-30
4
M
0
6250
A
184028
D
Ordinary Shares
2017-06-30
4
F
0
27885
4.03
D
156143
D
Ordinary Shares
2017-06-30
4
S
0
105039
3.979
D
51104
D
Ordinary Shares
2017-07-03
4
S
0
51104
4.0928
D
0
D
Restricted Stock Units
0.00
2017-05-15
4
A
0
108000
0.00
A
Ordinary Shares
108000
108000
D
Restricted Stock Units
0.00
2017-06-30
4
M
0
47187
0.00
D
Ordinary Shares
47187
377500
D
Restricted Stock Units
0.00
2017-06-30
4
M
0
6250
0.00
D
Ordinary Shares
6250
50000
D
The Ordinary Shares may be represented by American Depositary Shares, each of which represents one Ordinary Share.
Sales made pursuant to a 10b5-1 trading plan dated November 7, 2016.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.96 to $4.07, inclusive. The Reporting Person has provided the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of Ordinary Shares sold at each separate price.
Please see the section titled "Remarks" below for additional information.
As previously reported on July 8, 2015, the Reporting Person was granted 755,000 Restricted Stock Units ("RSUs") under the Amarin Corporation plc 2011 Stock Incentive Plan (the "Plan"). These RSUs vest in 16 equal quarterly installments. The eighth vesting event occurred on June 30, 2017.
Not applicable.
As previously reported on October 6, 2015, the Reporting Person was granted 100,000 RSUs under the Plan. These RSUs vest in 16 equal quarterly installments. The eighth vesting event occurred on June 30, 2017.
Represents withholding by the Issuer of shares in respect of tax liability incident to the vesting of a security issued in accordance with Rule 16b-3, and not a market sale of securities.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.96 to $4.03, inclusive. The Reporting Person has provided the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of Ordinary Shares sold at each separate price.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.05 to $4.14, inclusive. The Reporting Person has provided the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of Ordinary Shares sold at each separate price.
Each RSU represents a contingent right to receive one Ordinary Share or cash in lieu thereof at the Issuer's discretion.
On February 1, 2017, the Reporting Person was granted 108,000 RSUs under the Plan. These RSUs were subject to the approval by the Company's shareholders of an amendment to the Plan, which amendment was approved on May 15, 2017, and were previously disclosed in the Company's definitive proxy statement on Schedule 14A filed with the Securities and Exchange Commission on April 21, 2017. These RSUs vest in three equal installments on each of January 31, 2018, January 31, 2019 and January 31, 2020.
In the event of a Change of Control (as defined in the Plan), the grants described in this Form 4 vest in full. As of the date of this Form 4, the Reporting Person owns or holds the right to acquire an aggregate of 3,491,270 Ordinary Shares of the Issuer in the form of stock options and Restricted Stock Units granted under the Amarin Corporation plc 2002 Stock Option Plan and the Plan.
/s/ Joseph T. Kennedy
2017-07-03